Achiko AG Logo

Achiko AG

A digital services platform for cross-border business compliance and engagement.

ACHI | SW

Overview

Corporate Details

ISIN(s):
CH0522213468
LEI:
Country:
Switzerland
Address:
Tessinerplatz 7, 8002 Zürich

Description

Achiko AG operates as a platform for digital services. The company focuses on coordinating compliance and customer engagement for businesses expanding across borders. Its platform also provides content and services across a diverse range of sectors, including technology, lifestyle, and entertainment, with the goal of enhancing user engagement in the digital market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-06-20 02:00
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 t…
English 18.1 KB
2022-06-20 02:00
Achiko AG - Veröffentlichung des Geschäftsberichts und des Jahresabschlusses Ja…
German 10.1 KB
2022-06-10 23:15
Achiko AG Publication of Annual Report and Annual Financial Statements 2021…
English 22.5 KB
2022-06-10 02:00
Achiko AG – Publication of Annual Report and Annual Financial Statements 202…
English 22.1 KB
2022-06-10 02:00
Achiko AG - Veröffentlichung des Geschäftsberichts und des Jahresabschlusses Ja…
German 14.9 KB
2022-06-06 11:05
Achiko AG Publication of Annual Report and Annual Financial Statements 2021 t…
English 10.2 KB
2022-06-06 02:00
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 …
English 8.4 KB
2022-06-06 02:00
Achiko AG - Veröffentlichung des Geschäftsberichts und des Jahresabschlusses Ja…
German 8.9 KB
2022-05-31 06:45
Achiko AG Publication of Annual Report and Annual Financial Statements 2021 t…
English 10.3 KB
2022-05-31 02:00
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 …
English 8.4 KB
2022-05-31 02:00
Achiko AG - Veröffentlichung des Geschäftsberichts und des Jahresabschlusses Ja…
German 9.0 KB
2022-05-25 06:45
Achiko AG Secures CHF 1.25 million Financing with Strategic Investors Buranto …
English 10.5 KB
2022-05-19 08:26
Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 Decemb…
English 10.4 KB
2022-05-19 06:45
Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 Decemb…
English 10.1 KB
2022-05-17 06:45
Achiko AG Obtains CE Mark for AptameXTM Covid-19 Rapid Test
English 10.8 KB

Automate Your Workflow. Get a real-time feed of all Achiko AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Achiko AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Achiko AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG
Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.